• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCoronavirus

Coronavirus

Page 95 of 100
JAPAN-OMICRON-VARIANT-HEALTH-VIRUS
HealthDoes Omicron cause milder COVID? Do vaccines work against it? Three experts answer pressing questions about the new COVID variant
By Grady McGregorNovember 29, 2021
HealthGlobal drugmakers could roll out Omicron-adapted COVID vaccines in 100 days
By Yvonne LauNovember 29, 2021
Ray Dalio, founder of Bridgewater Associates LP, speaks during a Bloomberg Television interview at the Greenwich Economic Forum (GEF) in Greenwich, Connecticut, U.S., on Tuesday, Sept. 21, 2021.
NewslettersRay Dalio sees at least 3 reasons to worry about the future
By David Meyer and Alan MurrayNovember 29, 2021
NewslettersThe Omicron bounce: crypto, crude and stocks rebound as virus jitters ease
By Bernhard WarnerNovember 29, 2021
HealthOmicron appears to be producing more mild cases of COVID-19 so far. Public health officials are encouraged—but cautious
By Grady McGregorNovember 29, 2021
HealthHigh vaccine rates could limit the economic fallout of Omicron across Asia—but there’s one big caveat
By Eamon BarrettNovember 29, 2021
kids covid vaccine timeline
HealthThe new Omicron COVID variant is a stark reminder that we are still in the depths of the pandemic
By Marco Quiroz-GutierrezNovember 26, 2021
HealthWhat’s Omicron? Here’s what we know and don’t know about the new COVID variant that’s roiling markets and air travel
By David MeyerNovember 26, 2021
HealthMerck says its breakthrough COVID-19 pill doesn’t work nearly as well as previously reported
By Fiona Rutherford and BloombergNovember 26, 2021
The CoinsBitcoin and other crypto plunge as fear of new South Africa COVID variant routs markets
By Joanna Ossinger and BloombergNovember 26, 2021
JAPAN-STOCKS
Finance‘Taking no chances:’ Investors abandon travel stocks and seek safe havens as new, highly-mutated COVID variant spooks markets
By Yvonne Lau and David MeyerNovember 26, 2021
SOUTH AFRICA-EAST LONDON-COVID-19 VACCINATION
HealthNew COVID variant with ‘unusual constellation’ of mutations is already more dominant than Delta in South Africa
By Yvonne LauNovember 26, 2021
CommentaryTo avoid the superbug pandemic, we must fix the business model for new antibiotics
By Michelle McMurry-Heath and Henry SkinnerNovember 25, 2021
HealthSouth Africa has found a COVID-19 ‘mutation variant of serious concern’
By Prinesha Naidoo, S'thembile Cele and BloombergNovember 25, 2021
The two-shot regimen for younger kids is one-third the dose that’s given to people ages 12 and older.
HealthEurope approves Pfizer-BioNTech COVID-19 vaccine for kids from 5 to 11
By Naomi Kresge and BloombergNovember 25, 2021
1...
  • 93
  • 94
  • 95
  • 96
  • 97
...100
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO commander warnsAn image of a popular article
By Jason MaFebruary 28, 2026
AI
The week the AI scare turned real and America realized maybe it isn't ready for what's comingAn image of a popular article
By Nick LichtenbergFebruary 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.